Their focus on growth-hormone peptide stacks (CJC-1295, Ipamorelin, Sermorelin) and longevity peptides like Epitalon and MOTS-C aligns well with the most in-demand peptide categories in 2026
The optimal frequency and dosage varies person to person
Patients reporting fatigue, poor sleep, or low morning energy are among those most commonly evaluated for Ipamorelin-based protocols
TB-500, GHK-Cu, Melanotan II, and Epithalon are studied for other primary purposes and have weaker direct anti-inflammatory human evidence
Most critically, while the mechanistic and preclinical foundation is strong, clinical studies in humans would be required to establish optimal dosing, administration schedules, safety profiles, and actual synergistic effects for this specific combination